VNRX

VNRX

AMEX

VolitionRx Limited

0.2067

0.0167(8.79%)
Volume

351.9M

Market Cap

$20.61M

P/E Ratio

-1.93

EPS

$-0.31


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

-1.93

P/B Ratio

-2.08

EPS

$-0.31

ROE

103.29%

Profit Margin

-2,186.27%

Operating Margin

-2,190.90%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
ALGS
Aligos Therapeutics, Inc.
$6.95 -4.79% -2.98 $42.77M 0.10
BDSX
Biodesix, Inc.
$16.09 -3.01% -3.68 $121.50M -29.56
CTSO
Cytosorbents Corporation
$0.65 -4.41% -3.85 $40.83M 3.01
INMB
INmune Bio, Inc.
$1.24 -3.13% -0.66 $32.97M 0.04
MDCX
Medicus Pharma Ltd. Common Stock
$0.50 0.40% -0.32 $12.35M -0.26
MRSN
Mersana Therapeutics, Inc.
$29.08 0.00 -2.07 $145.36M -0.04
NOTV
Inotiv, Inc.
$0.36 -6.05% -0.18 $12.40M 4.85
SKYE
Skye Bioscience, Inc.
$0.67 0.48% -0.48 $21.58M 0.01
WGRX
Wellgistics Health, Inc.
$0.13 -14.22% -0.14 $9.37M 3.87
XLO
Xilio Therapeutics, Inc.
$7.60 2.29% -1.34 $39.88M -0.90

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$0.94

52 Week Low

$0.17

Dividend

$0.00

Dividend Yield

0.00%

About VolitionRx Limited

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.